PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
13-Dec-2022 Veranex Acquires Fusion Biotec to Continue Accelerating MedTech Diagnostic Solutions Businesswire
13-Dec-2022 Everest Group Names Medidata a ‘Leader’ and ‘Star Performer’ in Decentralized Clinical Trial Platforms Businesswire
13-Dec-2022 Tellius Names Josh Peltz Senior Vice President of Sales Businesswire
13-Dec-2022 UserTesting Helps Companies to Safely Test Health and Wellness Experiences with HIPAA-Compliant Feedback Businesswire
13-Dec-2022 Chimeron Bio Welcomes Kevin Heyeck as New CEO Businesswire
13-Dec-2022 BioGeNe Series 2023: A Platform for Pharmaceutical, Biotechnology Professionals and Technology Providers (San Diego, United States - February 8-9, 2023) - ResearchAndMarkets.com Businesswire
13-Dec-2022 Controlled & Modified Drug Release Summit 2023: The Next Generation of Drug and Therapeutic Delivery is Here (Princeton, NJ, United States - May 16-17, 2023) - ResearchAndMarkets.com Businesswire
13-Dec-2022 Ligand Provides Highlights from its Investor and Analyst Day Event Businesswire
13-Dec-2022 Arcturus Appoints John Markels, Ph.D. to its Board of Directors Businesswire
13-Dec-2022 NanoVibronix Announces Partnership with Peak Medical, Ltd. Businesswire
13-Dec-2022 Bryn Pharma Appointments Jeff Hartness to its Board of Directors Businesswire
13-Dec-2022 EFFECT Photonics Partners with Fabrinet to Scale Production of Highly Integrated Optical Solutions Businesswire
13-Dec-2022 ImmunoTek Plasma Expands in Louisiana Businesswire
13-Dec-2022 Calidi Biotherapeutics Receives Funding from the California Institute for Regenerative Medicine (CIRM) to Advance SuperNova-1 and NeuroNova-2 Development Programs Businesswire
13-Dec-2022 MAIA Biotechnology Expands Phase 2 THIO-101 Trial to Europe Businesswire
13-Dec-2022 Aldeyra Therapeutics’ Investigational RASP Modulator ADX-629 Improved Signs of Intoxication in Alcohol Challenge Phase 2 Clinical Trial Businesswire
13-Dec-2022 8th Annual Biomarker and Companion Diagnostics Conference: Leveraging Next-Gen Technologies Beyond Conventional Biomarker Drug Discovery (San Diego, United States - February 8-9, 2023) - ResearchAndMarkets.com Businesswire
13-Dec-2022 Hygieia adds to team, continues rapid, national expansion of its d-Nav® Insulin Management Program Businesswire
13-Dec-2022 No Opioids After Surgery: Evonik Invests in Allay Therapeutics and Supplies Key Technology for Pain Therapy Implants Businesswire
13-Dec-2022 ICON recognised as leading contract research organisation and employer by Scrip, Fierce Life Sciences, Financial Times and others Businesswire